Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fisher Expanding In-House Manufacturing Capability Through Cole-Parmer

This article was originally published in The Gray Sheet

Executive Summary

Fisher Scientific International will broaden its offerings of instrumentation and equipment used in life-science research and increase its in-house manufacturing capabilities through acquisition of privately held Cole-Parmer Instrument Company.

You may also be interested in...



Fisher Casts For Proteomics Consumables; Perbio Deal Offers Device Angle

Fisher Scientific will explore the viability of Perbio Science AB's medical device unit within a planned merger of the two companies, announced June 26

Fisher Casts For Proteomics Consumables; Perbio Deal Offers Device Angle

Fisher Scientific will explore the viability of Perbio Science AB's medical device unit within a planned merger of the two companies, announced June 26

Fisher Scientific International

Secondary offering of 12 mil. shares at $24 each, including 11 mil. shares offered by the firm and 1 mil. shares offered by selling shareholders, is announced May 3. Proceeds will be used for general corporate purposes, "including potential acquisitions," Fisher says. The Hampton, New Hampshire firm has granted an over-allotment option to purchase an additional 1.8 mil. shares to underwriters Goldman Sachs, Credit Suisse First Boston, JP Morgan, Merrill Lynch, and Morgan Stanley. Fisher's proposal to merge with medical products distributor PSS World Medical was terminated in September 2000 (1"The Gray Sheet" Sept. 11, 2000, p. 24). At the time, the firm said it would continue to seek other acquisitions

UsernamePublicRestriction

Register

LL035386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel